Clinical Trial

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, observational post-market registry collecting outcomes through a 10-year post procedure follow-up for patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device) or the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device) as a part of routine clinical practice.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-01-11; most recent amendment 2026-02-02.
Status change: Not Yet Recruiting → Recruiting 2024-05-13
Trial Details
NCT Number NCT06218875
Lead Sponsor W.L.Gore & Associates
Conditions AAA - Abdominal Aortic Aneurysm
Enrollment 2,000 participants
Start Date 2024-05-07
Primary Completion 2042-09-30 (estimated)
Study Completion 2042-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-05